AzTrials
AzTrials

U/S Guided SAB VS U/S Guided SAB Combined With Modified Pectoral Nerve BlockNCT05006612

U/S Guided SAB VS U/S Guided SAB With Modified Pectoral Nerve Block in Modified Radical Mastectomy

A study testing Serratus Anterior Plane Block in people with U/S Guided SAB VS U/S Guided SAB Combined With Modified Pectoral Nerve Block, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We hypothesize that ultrasound guided serratus anterior plane block Combined With Modified Pectoral Nerve Block is going to be more effective than Ultrasound guided Serratus anterior plane block alone in patients undergoing MRM as modified Pecs block involves the block of medial and lateral pectoral nerves which are… Read more about this study

Who is it for?
Ages 18 to 65 years, women onlyHealthy volunteers can take part
What is being tested?
Serratus Anterior Plane Block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
14 Jun 2021to 23 Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Female patients
  • Type of surgery; Modified Radical Mastectomy (MRM)
  • Physical status ASA I, II, III.
  • Age ≥ 18 and ≤ 65 Years.
  • Body mass index (BMI): > 20 kg/m2 and < 35 kg/m2.

Who cannot join

  • Age <18 years or >65 years
  • BMI <20 kg/m2 and >35 kg/m2
  • Known sensitivity or contraindication to drug used in the study (local anaesthetics, opioids).
  • History of psychological disorders and/or chronic pain.
  • Contraindication to regional anaesthesia e.g. local sepsis, pre- existing peripheral neuropathies and coagulopathy.
  • Patient refusal.
Show all 10Show fewer
  • Severe respiratory or cardiac disorders.
  • Advanced liver or kidney disease.
  • Pregnancy.
  • Physical status ASA IV and Male patients.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ahmed Abdalla Mohamed

    Cairo, 11451

Other trials in Egypt

About this study

Official title: U/S Guided SAB VS U/S Guided SAB With Modified Pectoral Nerve Block in Modified Radical Mastectomy,Randomized Double Blinded Comparative Study

We hypothesize that ultrasound guided serratus anterior plane block Combined With Modified Pectoral Nerve Block is going to be more effective than Ultrasound guided Serratus anterior plane block alone in patients undergoing MRM as modified Pecs block involves the block of medial and lateral pectoral nerves which are spared in case of serratus block alone, resulting in reducing myofascial pain and opioid consumption.

Read the detailed description

Ultrasound guided Serratus anterior plane block was introduced in 2013 for analgesia of breast and lateral thoracic wall surgery. At the axillary fossa, the intercostobrachialis nerve, lateral cutaneous branches of the intercostal nerves (T3-T9), long thoracic nerve, and thoracodorsal nerve are located in a compartment between the serratus anterior and the latissimus dorsi muscles, between the posterior and midaxillary lines at this plane local anesthetic will be injected . Complications of serratus anterior plane block include local anesthetic toxicity and pneumothorax , unfortunately medial and lateral pectoral nerves are preserved which are responsible for the myofacial pain .

The pectoral nerves (Pecs) block types I and II (Modified Pectoral block) , is less invasive technique described by Blanco et al where local anesthetic is deposited into the plane between the pectoralis major muscle(PMm) and the pectoralis minor muscle (Pmm) (Pecs I block)and above the serratus anterior muscle at the third rib (Pecs IIblock).,Blocking intercostobrachial, third to sixth intercostals the long thoracic nerves in addition to medial and lateral pectoral nerves.

Addition of Modified Pecs block to Serratus anterior plane block will enhance the control of pain as it block the medial and lateral pectoral nerves which are responsible for the myofacial pain and which are spared in case of Serratus block alone .

Being tested
Serratus Anterior Plane Block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Serratus Anterior Plane BlockProcedure or surgery

    Also called Serratus Anterior Plane Block SAPB combined with Modified Pectoral Nerve Block

    SAPB Technique; U/S probe will be placed on the patient's midaxillary line in the transverse plane, at the level of the fifth rib, Then, using U/S guidance, A 38-mm 22-gauge regional block needle is advanced in-plane at an angle of approximately 45 degrees towards the fifth rib. After aspiration to avoid IV injection 30ml of levobupivacaine 0.25% is injected anteriorly to the rib and deep to the serratus anterior muscle.

    SAPB combined with Modified Pectoral Nerve Block :

    SAPB with injection of 20 ml levobupivacaine 0.25% as discussed before. Modified Pectoral Nerve Block:After identification of the axillary vessels, the U/S probe will turned inferolaterally till the serratus anterior and the two pectoralis muscles are detected in one plane. 10 ml of levobupivacaine 0.25%was injected between the two pectoralis muscles. After that,10 mL of levobupivacaine 0.25%is injected above this muscle.

Study groups in NCT05006612
Study groupRoleWhat they receive
Group 1 ((Serratus Anterior Plane Block SAPB)Active comparatorN=3o Patients will receive Ultrasound guided Serratus Anterior Plane Block with injection of 30 ml levobupivacaine 0.25%.
Receives: Procedure: Serratus Anterior Plane Block
Group 2 ((Serratus Anterior Plane Block SAPB combined with Modified Pectoral Nerve Block)Active comparatorN=3o Patients will receive Ultrasound guided Serratus Anterior Plane Block with injection of 20 ml levobupivacaine 0.25%and Modified Pectoral Nerve Block with injection of 10 ml levobupivacaine 0.25%between the two pectoralis muscles, after that, the probe was turned toward the axilla, and as the serratus anterior muscle was recognized above the third and fourth ribs, 10 mL of levobupivacaine 0.25% was injected above this muscle
Receives: Procedure: Serratus Anterior Plane Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The total amount of morphine consumption in the first 24 hours postoperatively

    The total amount of morphine consumption in the first 24 hours postoperatively

    Measured: Through Study Completion

Secondary outcomes (9)
  1. Total amount of intraoperative fentanyl will be recorded.

    Total amount of intraoperative fentanyl will be recorded.

    Measured: Through Study Completion over the first 24 hrs postoperative

  2. Change in heart rate and mean arterial blood pressure intraoperatively at 30 minutes interval in comparison to baseline reading.

    Change in heart rate and mean arterial blood pressure intraoperatively at 30 minutes interval in comparison to baseline reading.

    Measured: Through Study Completion over the first 24 hrs postoperative

  3. The degree of postoperative sedation according to Ramsay scores

    postoperative sedation according to Ramsay scores

    Measured: Through Study Completion over the first 24 hrs postoperative .

  4. Heart rate, mean arterial blood pressure and VAS (at rest and during movement) at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively.

    Change in hemodynamics ((heart rate and mean arterial blood pressure)

    Measured: Through Study Completion over the first 24 hrs postoperative

  5. Postoperative nausea and vomiting (PONV) as side effects of morphine.

    Nausea and vomiting Scores using a four-point verbal scale:

    Measured: Through Study Completion over the first 24 hrs postoperative

  6. Time of first rescue analgesia

    Time of first rescue analgesia

    Measured: Through Study Completion over the first 24 hrs postoperative

  7. Complications related to blocks such as local anaesthetic systemic toxicity, pneumothorax and arterial puncture (US check postoperative).

    Complications related to blocks such as local anaesthetic systemic toxicity, pneumothorax and arterial puncture

    Measured: Through Study Completion over the first 24 hrs postoperative

  8. Morphine related complications such as respiratory depression, urine retention or pruritis

    Morphine related complications such as respiratory depression, urine retention or pruritis

    Measured: Through Study Completion over the first 24 hrs postoperative

  9. Patient satisfaction the patient will be classified in this group to satisfied or not.

    Patient satisfaction the patient will be classified in this group to satisfied or not.

    Measured: Through Study Completion over the first 24 hrs postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2021
  2. Study start14 Jun 2021
  3. Primary completion16 Aug 2021
  4. Study completion23 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
To determine the analgesic effect of ultrasound guided Serratus anterior block combined with modified pectoral nerve block compared to ultrasound guided Serratus Anterior block in patients undergoing modified radical mastectomy regarding the following : 1-Post-operative opioid (morphine) consumption in the 1st 24 hours 2- Post-operative Numeric Pain Rating Scale. 3\. Effect on hemodynamics: Mean arterial blood pressure and Heart rate. 4\. Intraoperative fentanyl consumption. 5\. Duration of analgesic effect
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05006612
Sponsor's protocol ID
MS-201-2021
Status last verified
Jul 2022
First submitted
21 Jul 2021
Last updated
19 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Till publication

Questions about this trial

What is this clinical trial studying?

A study testing Serratus Anterior Plane Block in people with U/S Guided SAB VS U/S Guided SAB Combined With Modified Pectoral Nerve Block, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The total amount of morphine consumption in the first 24 hours postoperatively (time frame: Through Study Completion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2022; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in